Prescriber Acceptability of a Direct-to-Patient Intervention for Benzodiazepine Receptor Agonist Deprescribing and Behavioural Management of Insomnia in Older Adults

Andrea L Murphy,Justin P Turner,Malgorzata Rajda,Kathleen G Allen,David M Gardner,Andrea L. Murphy,Justin P. Turner,Kathleen G. Allen,David M. Gardner
DOI: https://doi.org/10.1017/s0714980824000114
2024-03-09
Canadian Journal on Aging / La Revue canadienne du vieillissement
Abstract:Behavioural treatments are recommended first-line for insomnia, but long-term benzodiazepine receptor agonist (BZRA) use remains common and engaging patients in a deprescribing consultation is challenging. Few deprescribing interventions directly target patients. Prescribers' support of patient-targeted interventions may facilitate their uptake. Recently assessed in the Your Answers When Needing Sleep in New Brunswick (YAWNS NB) study, Sleepwell (mysleepwell.ca) was developed as a direct-to-patient behaviour change intervention promoting BZRA deprescribing and non-pharmacological insomnia management. BZRA prescribers of YAWNS NB participants were invited to complete an online survey assessing the acceptability of Sleepwell as a direct-to-patient intervention. The survey was developed using the seven construct components of the theoretical framework of acceptability (TFA) framework. Respondents (40/250, 17.2%) indicated high acceptability, with positive responses per TFA construct averaging 32.3/40 (80.7%). Perceived as an ethical, credible, and useful tool, Sleepwell also promoted prescriber–patient BZRA deprescribing engagements (11/19, 58%). Prescribers were accepting of Sleepwell and supported its application as a direct-to-patient intervention.
geriatrics & gerontology,gerontology
What problem does this paper attempt to address?
The paper attempts to address the issue of long-term use and tapering of benzodiazepine receptor agonists (BZRA) in the elderly. Specifically: - **Background Issue**: Long-term use of BZRA (including benzodiazepines and Z-drugs) has negative effects on the cognitive and physical health of the elderly, increasing a range of health risks such as falls, cognitive impairment, and affecting quality of life. - **Recommended Therapy**: Although behavioral therapies (such as CBTi) are recommended as the first-line treatment for insomnia, the use of BZRA remains prevalent. However, engaging patients in tapering consultations is very challenging. - **Research Objective**: To evaluate the effectiveness and acceptability of a patient-directed intervention—Sleepwell. Sleepwell aims to help patients reduce BZRA use through educational materials and manage insomnia using non-pharmacological methods. The paper evaluates whether Sleepwell, as a patient-directed intervention, can be accepted by doctors through a randomized controlled trial (YAWNS NB). The results show that most doctors consider Sleepwell to be an ethical, credible, and useful tool, and support its application as a patient-directed intervention.